cellQART®

Save the Date: ACT Annual Meeting 2024 – Meet Us in Austin! 🏢 From November 18th to 19th, 2024, we’ll exhibit at the JW Marriott Hotel, Austin, Texas at the American College of Toxicology (ACT) Annual Meeting. Join our colleague Jennifer Hughes as we connect with fellow professionals in toxicology and safety assessment. Don’t miss out on innovative scientific sessions and great networking opportunities. 📅 Mark your calendars: November, 18th to 19th! 📍 Booth 316 – JW Marriott, Austin, Texas #Toxicology #SafetyAssessment #ACT2024 #Networking #ScientificInnovation

New insights in cell culture🧫– dive into research with us | paper series part 16 In this paper, Lutz et al. developed mucin-based particles that are excellent candidates for a drug carrier system that can be administered via the gastrointestinal tract. Our cellQART 0.4 micron pore size translucent inserts were used to perform enzymatic degradation tests with the mucin particles.🔬 ➡ For more information check out the link in the comments and visit our cellQART Academy. Lutz, T. M., Kimna, C. & Lieleg, O. A pH-stable, mucin based nanoparticle system for the co-delivery of hydrophobic and hydrophilic drugs. Int. J. Biol. Macromol. 215, 102–112 (2022). #cellculture #science #research #paper

New insights in cell culture 🧫– dive into research with us | paper series part 15   In this paper, Basmaeil et al. evaluated the effects of placenta-derived decidua parietalis mesenchymal stem/stromal cells on the functional outcome of human breast cancer cell line MDA231. Our cellQART 0.4 micron pore size translucent inserts were used to co-culture placenta-derived decidua parietalis mesenchymal stem/stromal cells seeded in the reverse side of the membrane and the MDA231 were seeded in the upper chamber.🔬   ➡ For more information check out the link in the comments and visit our cellQART Academy.   Basmaeil, Y. et al. Decidua Parietalis Mesenchymal Stem/Stromal Cells and Their Secretome Diminish the Oncogenic Properties of MDA231 Cells In Vitro. Cells 10 , 3493 (2021). #cellculture #science #research #paper

Save the Date for EUSAAT in Austria at the University of Linz🏫 Visit us at EUSAAT 2024 from 18 to 20 September and experience true innovation in the field of cell culture technology. 🔍 Be there and look into the future of research with us! Our CEO, Dennis Benkmann, will be there to answer all your questions and give you expert advice during the event. 💬👨💼 Don't miss this unique opportunity to discover our high-quality products at EUSAAT 2024! 🌐🧬 We look forward to welcoming you there! 🤝😊 #EUSAAT2024 #CellCulture #Innovation #Research #Biotech

New insights in cell culture🧫– dive into research with us | paper series part 14   In this paper, Hameedat et al. developed and characterized candidate protein delivery systems for the pulmonary administration of peptides. Our cellQART 1.0 micron pore size inserts were used to build a lung monoculture model and a lung co-culture model to perform insulin permeability assays.🔬   ➡ For more information check out the link in the comments and visit our cellQART Academy.   Hameedat, F., Pinto, S., Marques, J., Dias, S. & Sarmento, B. Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides. Drug Deliv. and Transl. Res. 13, 1699–1715 (2023). #cellculture #science #research #paper

New insights in cell culture🧫– dive into research with us | paper series part 13 In this paper, Pop et al. assessed AXL expression on tissue macrophages in patients with cirrhosis.  Our cellQART 0.4 micron pore size translucent inserts were used to co-culture hepatic macrophages with LX-2 cells, primary hepatic stellate cells, or treatment with GAS6.🔬 ➡ For more information check out the link in the comments and visit our cellQART Academy. Pop, O.-T. et al. AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells. Cell. Mol. Gastroenterol. Hepatol. 0, (2023). #cellculture #science #research #paper

The ESTIV conference in Prague has concluded, and we are grateful for the incredible experience. We extend our heartfelt thanks to the ESTIV organizers and the visitors who made this event a success. We look forward to participating in the next conference with the scientific community. 🧫🔬

Happy 4th Anniversary, cellQART®! 🎉🎂 Today we celebrate a significant milestone – cellQART® turns 4 years! 🎊 What started as a vision has grown into a respected brand that enables our users to create a safer, healthier, and more ethical world. 🌍🧬 Over the past four years, we have consistently pursued our mission: Enabling reproducible results during cell-based experiments. With our cellQART® Cell Culture Products, we are committed to the 3Rs principle of reducing, refining, and replacing animal testing while advancing human benefit. 🧪🔬 From our first groundbreaking product to our expanded portfolio today, we have strived to integrate the latest technological advancements. Over 50 application reports have already been published in which our Cell Culture Products were used. You can find and read them in our Academy. 📚📈 Recently we have published our 12-Well empty and pre-loaded plates and are proud to say that we can offer all our 6, 12 & 24 Well-Plates in translucent and clear membrane optic. You can also order our clear extended culture with 0.4 µm. 🥼🧫 This journey would not have been possible without the unwavering support of our loyal customers and partners. Your trust and satisfaction are our greatest motivators. We extend our thanks for making cellQART® what it is today. 🙏🤝 Our commitment remains: to exceed your expectations and offer the best solutions. Thank you for being part of this incredible journey. 🎈🚀 #birthday #cellQART #cellculture #insert

We're thrilled to announce our participation at the European Society of Toxicology in Vitro ESTIV Congress 2024 in Prague (Czech Republic), where we'll be presenting our groundbreaking cellQART products. 📢 Join us at ESTIV 2024 from June 3rd to June 6th for an unforgettable experience! 🗓️🎉 Make sure to save the date for this event! It's your chance to explore our latest innovations and solutions. Our CEO, Dennis Benkmann, will be present to address all your inquiries and provide expert guidance throughout the event. 👨💼🔍 Don't miss out on this incredible opportunity to discover our premium products at the ESTIV Congress 2024! Let us know in the comments if you will be there! 🙌 #ESTIV2024 #Prague #cellQART #Innovation #SaveTheDate